424 Results (Page 3 of 17)
Germany Markets Research Reports
Germany End-stage Renal Disease(ESRD) Market Analysis
Germany End-stage renal disease (ESRD) Market Analysis is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the End-stage renal disease (ESRD) market include the increasing prevalence of chronic kidney diseases, advancements in renal replacement therapies, growing demand for kidney transplantation, government initiatives and healthcare policies supporting renal care, and the aging population. Global Players in the ESRD Market are Fresenius Medical Care AG & Co. KGaA, DaVita Inc., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Nikkiso Co., Ltd., Asahi Kasei Medical Co., Ltd., Medtronic plc, Terumo Corporation and Rockwell Medical, Inc.
Germany Endometriosis Drugs Market Analysis
Germany Endometriosis Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Drivers of the Endometriosis Drugs market include the increasing prevalence of endometriosis, growing awareness and diagnosis, demand for effective pain management, technological advancements in drug development, and supportive government initiatives. These factors contribute to market growth by addressing unmet needs and improving access to treatment options for endometriosis patients. Global Players in the Endometriosis Drugs Market are AbbVie Inc., Pfizer Inc., Bayer AG, Eli Lilly and Company, Johnson & Johnson, AstraZeneca PLC, Novartis International AG, Teva Pharmaceutical Industries Ltd., Merck & Co. and Takeda Pharmaceutical Company Limited.
Germany Enzymatic Wound Debridement Market Analysis
Germany Enzymatic Wound Debridement Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Growing prevalence of chronic wounds and diabetic ulcers, Advancements in enzymatic debridement technology, increasing demand for non-invasive and painless wound debridement methods and rising geriatric population prone to chronic wounds are drivers in Enzymatic Wound Debridement Market. Global Companies in the Enzymatic Wound Debridement Market are Smith & Nephew plc, Mölnlycke Health Care AB, B. Braun Melsungen AG, Coloplast A/S, ConvaTec Group plc, Paul Hartmann AG, Hollister Incorporated, Integra LifeSciences Corporation, Organogenesis Inc. and Misonix Inc.
Germany Enzyme Inhibitors Market Analysis
Germany Enzyme Inhibitors Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing prevalence of enzyme-related disorders, advances in drug discovery and development, a greater emphasis on personalized therapy, and increased research spending and collaborations are driving the enzyme inhibitors market. Novartis International AG, Roche Holding AG, AstraZeneca PLC, GlaxoSmithKline plc, Sanofi S.A., Boehringer Ingelheim International GmbH, Bayer AG, Takeda Pharmaceutical Company Limited, AbbVie Inc., and Merck KGaA are the global participants in the enzyme inhibitors market.
Germany Epigenetics Market Analysis
Germany Epigenetics Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Factors driving this market growth include an increase in the incidences of infectious diseases, cancer, chronic conditions, and genetic conditions; rising healthcare spending, which, according to the American Medical Association, will exceed $187.6 billion in 2021; and growing interest in bioinformatics, the market for which will reach $10 billion in revenue in 2022. Global key players in the epigenetics market include Illumina Inc., Thermo Fisher Scientific Inc., QIAGEN N.V., Merck KGaA, and Abcam plc.
Germany Epilepsy Drugs Market Analysis
Germany Epilepsy Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of epilepsy, increasing incidences of brain cancer in the geriatric population, and extensive research and development (R&D) activities represent some of the key factors driving the market. Some of the prominent global players in the epilepsy drugs market include Pfizer Inc., UCB S.A., GlaxoSmithKline plc, Novartis AG, and Eisai Co., Ltd.
Germany Gastroesophageal Reflux Disease (GERD) Drugs Market Analysis
Germany Gastroesophageal Reflux Disease (GERD) Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The high prevalence of GERD, rising awareness and diagnostic rates, technology improvements, and lifestyle variables are all driving factors in the Gastroesophageal Reflux Disease (GERD) medications market. Some prominent global players in the Gastroesophageal Reflux Disease (GERD) drugs market include AstraZeneca PLC, Pfizer Inc., Takeda Pharmaceutical Company Limited, Johnson & Johnson, GlaxoSmithKline plc, Eli Lilly and Company, AbbVie Inc., Mylan N.V., Perrigo Company plc, and Sun Pharmaceutical Industries Ltd.
Germany Gastrointestinal Drugs Market Analysis
Germany Gastrointestinal Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The rising prevalence of gastrointestinal problems, caused by factors such as changing lifestyles, dietary habits, and an ageing population, is one of the main drivers for gastrointestinal medications. Technological advances in drug research and targeted medicines, which provide more effective treatment alternatives, also contribute to market growth. Furthermore, as people become more aware of and diagnose gastrointestinal diseases, the need for medications to treat these conditions grows. Pfizer Inc., Johnson & Johnson, AbbVie Inc., Takeda Pharmaceutical Company Limited, AstraZeneca PLC, GlaxoSmithKline plc, Bristol Myers Squibb Company, Eli Lilly and Company, Merck & Co., Inc., and Allergan plc are among the major global competitors in the gastrointestinal drugs market.
Germany Generic and Biosimilar Pharmaceutical Market Analysis
Germany Generic and Biosimilar Pharmaceutical Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The generic and biosimilar pharmaceutical market is driven by cost-effectiveness, patent expirations, rising healthcare demand, and government cost-cutting initiatives. Teva Pharmaceutical Industries Ltd., Mylan N.V., Sandoz International GmbH (Novartis), Pfizer Inc., Amgen Inc., Biocon Ltd., Dr. Reddy's Laboratories Ltd., Fresenius Kabi AG, Celltrion Inc., and Stada Arzneimittel AG are global companies in the Generic and Biosimilar Pharmaceutical Market.
Germany Glaucoma Drugs Market Analysis
Germany Glaucoma Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing prevalence of glaucoma, caused by factors such as an ageing population and rising awareness, is a driver of the glaucoma medications industry. Drug delivery system technological improvements help to increase treatment choices. Novartis AG, Pfizer Inc., Santen Pharmaceutical Co., Allergan (AbbVie Inc.), Bausch Health Companies Inc., Alcon (a part of Novartis AG), Merck & Co., Aerie Pharmaceuticals, Sun Pharmaceutical Industries Ltd., and Santen Inc. are the global players in the Glaucoma Drugs Market.
Germany Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market Analysis
Germany Glucagon Like Peptide-1 (GLP-1) Receptor Agonist Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the GLP-1 receptor agonist market include their efficacy in controlling blood sugar levels, additional benefits like weight loss and cardiovascular risk reduction, rising prevalence of type 2 diabetes, and increasing awareness of diabetes management, leading to growing demand for these medications. Novo Nordisk A/S, Eli Lilly and Company, AstraZeneca plc, Sanofi S.A., Merck & Co., Inc., Boehringer Ingelheim International GmbH and Zealand Pharma A/S are global key players in the market.
Germany Glucaric Acid Market Analysis
Germany Glucaric Acid Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the glucaric acid market include the growing demand in various industries, driven by its applications and eco-friendly properties, increased consumer awareness of sustainability, and ongoing research and development efforts to explore new applications and production methods for glucaric acid. Global Players in Glucaric Acid Market are Rennovia Inc., Rivertop Renewables, Haihang Industry Co., Hebei Long Hai Import and Export Trade Co., Haihang Industry (Jinan) Co., Alfa Chemistry, Tokyo Chemical Industry Co., AK Scientific and Biosynth Carbosynth.
Germany Glutathione Market Analysis
Germany Glutathione Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increased prevalence of chronic diseases, demand in the cosmetics and beauty industry, and sports nutrition and performance enhancement are key drivers of the glutathione market. Kyowa Hakko Bio Co., Shandong Jincheng Biological Pharmaceutical Co., Kohjin Life Sciences, NOW Health Group, Merck KGaA, Kaiping Genuine Biochemical Pharmaceutical Co., Mitsubishi Tanabe Pharma Corporation, Shenzhen GSH Bio-Technology Co., Energetic Nutrition, and TCI Chemicals are the global players in the glutathione market.
Germany Gram Positive Bacterial Infections Market Analysis
Germany Gram Positive Bacterial Infections Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gram-positive bacterial infections market include the increasing prevalence of these infections, the emergence of antibiotic resistance, technological advancements in diagnostics and treatments, and the growing healthcare infrastructure, leading to higher demand for effective treatments and the need for innovative solutions to combat these infections. Global Players in Gram positive Bacterial Infections market are Pfizer Inc., Merck & Co., GlaxoSmithKline, Novartis AG, Sanofi S.A., Johnson & Johnson Services, AbbVie Inc., Bayer AG, AstraZeneca plc and Eli Lilly and Company.
Germany Gynecology Drugs Market Analysis
Germany Gynecology Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the gynecology drugs market include the increasing prevalence of gynecological disorders, growing awareness and focus on women's health, technological advancements, and supportive government initiatives promoting women's healthcare. Key Global Players in Gynecology Drugs Market are Bayer AG, Pfizer Inc., Merck & Co., Novartis AG, Johnson & Johnson, AbbVie Inc., Allergan plc, Eli Lilly and Company, AstraZeneca plc and GlaxoSmithKline plc.
Germany H1N1 Vaccines Market Analysis
Germany H1N1 Vaccines Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the H1N1 vaccines market include global outbreaks and pandemics, government initiatives and vaccination programs, increasing awareness, and advancements in vaccine development and production. Key global players in H1N1 vaccines market are Sanofi Pasteur, GlaxoSmithKline plc, Seqirus (a subsidiary of CSL Limited), AstraZeneca plc, Sinovac Biotech Ltd., Hualan Biological Engineering Inc., Changchun BCHT Biotechnology Co., Serum Institute of India Pvt. Ltd., Daiichi Sankyo Company, and Novartis AG.
Germany Haematology Market Analysis
Germany Haematology Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The increasing frequency of blood disorders, technological improvements, the growing elderly population, and increased desire for customised medicine and focused therapies are key drivers of the haematology market. Abbott Laboratories, Sysmex Corporation, Roche Diagnostics, Siemens Healthineers, Bio-Rad Laboratories, Thermo Fisher Scientific Inc., Danaher Corporation (Beckman Coulter), HORIBA Ltd., Ortho Clinical Diagnostics, and Agilent Technologies are the global players in the haematology market.
Germany Hangover Rehydration Supplements Market Analysis
Germany Hangover Rehydration Supplements Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The growing ageing population and prevalence of chronic diseases, breakthroughs in medication discovery and technology, and increased access to healthcare in emerging economies are all key drivers of the Hangover Rehydration Supplements Market. Gatorade (PepsiCo), Pedialyte (Abbott Laboratories), Liquid IV, Flyby, Blowfish for Hangovers, Cheers Health Inc., Bytox, Morning Recovery, Resync Recovery Blend, and Hydrant are the global key players in the Hangover Rehydration Supplements Market.
Germany Head and Neck Cancer Drugs Market Analysis
Germany Head and Neck Cancer Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Key drivers of the head and neck cancer drugs market in the USA include the increasing incidence of head and neck cancer, advancements in treatment options, rising demand for personalized medicine, and supportive government initiatives. Global Companies in Head and Neck Cancer Drugs Market are Bristol Myers Squibb Company, Merck & Co., Inc., Pfizer Inc., AstraZeneca plc, Novartis AG, Eli Lilly and Company, Amgen Inc., GlaxoSmithKline plc, Johnson & Johnson, Sanofi, Roche Holding AG, Takeda Pharmaceutical Company Limited, Bayer AG, AbbVie Inc. and Eisai Co., Ltd.
Germany Heart Failure Drugs Market Analysis
Germany Heart Failure Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The drivers of the heart failure drugs market include the increasing prevalence of heart failure, the aging population, advancements in drug therapies, rising awareness and diagnosis, and supportive government initiatives. Novartis AG, Pfizer Inc., AstraZeneca plc, Johnson & Johnson, Merck & Co., Bristol Myers Squibb Company, Boehringer Ingelheim International GmbH, Bayer AG, GlaxoSmithKline plc and Amgen are global key players in Heart Failure Drugs market.
Germany Hematopoietic Stem Cell Transplantation Market Analysis
Germany Hematopoietic Stem Cell Transplantation Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Two significant drivers driving the global market expansion for hematopoietic stem cell transplantation are leukaemia and lymphoproliferative disorders. Rising technical advancements and significant companies spending more money on R&D are expected to drive the market. Some of the major key players are Escape Therapeutics, Kite Pharma Inc., PromoCell GmbH, ScienCell Research Laboratories etc.
Germany Heparin Market Analysis
Germany Heparin Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. Deep vein thrombosis (DVT) and pulmonary embolism (PE), expanding cardiac disorders, rising federal funding for improving health services and comprehensive research and development (R&D) activities, the rising incidence of chronic diseases, and the ageing population are some of the market drivers influencing the growth of the heparin market. The global Heparin market’s major key players are Sanofi S.A., Viatris Inc., Pfizer Inc., B. Braun Holding GmbH & Co. KG, etc.
Germany Hepatitis B Drugs Market Analysis
Germany Hepatitis B Drugs Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 - 2030. The factors such as growth of pharmaceutical industry, increase in ageing population, upsurge in healthcare expenditure, urbanization leading to better monitoring and screening procedures and increase in liver cancer and cirrhosis deaths due to HBV would drive the growth of Hepatitis B drugs market. Some of the major key players in this market are Apotex Inc, Accord Healthcare, Arbutus Biopharma, Aurobindo Pharma, Arrowhead Pharmaceuticals, Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences, Inc., Lupin Pharmaceuticals, Inc., etc.
Germany Hepatitis C Drugs Market Analysis
Germany Hepatitis C drugs market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. The market will grow as a result of a number of factors, including the expansion of the pharmaceutical sector, an ageing population, growing healthcare expenditures, urbanisation, better monitoring and screening technologies, and a rise in liver cancer and cirrhosis fatalities brought on by HBV. Some of the major key players in this market are Bristol-Myers Squibb Company Gilead Sciences, Inc. Abbvie Kadmon Holdings Inc. F. Hoffmon La Roche Ltd. GlaxoSmithKline J & J Lupin Pharmaceuticals, Inc. Merck & Co., Inc. Teva Pharmaceuticals and Zydus Pharmaceuticals.
Germany HER-2 Negative Breast Cancer Market Analysis
Germany HER-2 Negative Breast Cancer Market is projected to grow from $xx Mn in 2022 to $xx Mn by 2030, registering a CAGR of xx% during the forecast period of 2022 – 2030. A number of factors, such as age, obesity, alcoholism, radiation exposure history, family history of breast cancer, family history of the disease, age at first pregnancy, onset of the menstrual cycle, and tobacco use, increase the risk of developing the disease. As a result of lifestyle changes, the incidence and prevalence of breast cancer are rising quickly. All of this will drive a HER-2 Negative Breast Cancer Market.The global HER-2 Negative Breast Cancer market’s major key players are Pfizer, Novartis AG Merck & Co. Inc., GlasxoSmithKline, Eli Lilly and Company, Bristol Myers Squibb Company, AstraZeneca, Lupin, Bayer AG.